← naar grote beleggers
Cormorant Asset Management, LP
institutionele belegger · portefeuille $1.95 mld. · 50 posities · rapport per 30.06.2026
Aandelenposities rapport over 30.06.2026, ingediend op 14.08.2026; verandering — t.o.v. 31.03.2026 · 0
| Bedrijf | Aandelen | Waarde | % van de portefeuille | Verandering per kwartaal |
|---|
In bedrijven uit onze database 18
| Bedrijf | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| BridgeBio Oncology Therapeut… | 22.3% | 17 878 594 | 2026-06-30 |
| Corbus Pharmaceuticals Holdi… | 12.56% | 2 344 971 | 2026-06-30 |
| Bright Minds Biosciences Inc | 9.25% | 900 000 | 2026-06-30 |
| Helix Acquisition Corp. III… | 7.31% | 1 297 500 | 2026-06-30 |
| Adlai Nortye Group Ltd. | 6.77% | 3 978 229 | 2026-06-30 |
| iBio, Inc. | 5.55% | 3 570 000 | 2026-06-30 |
| Rapport Therapeutics, Inc. | 5.54% | 2 657 521 | 2026-06-30 |
| BioAge Labs, Inc | 5.21% | 2 390 605 | 2026-06-30 |
| AgomAb Therapeutics NV | 5.01% | 2 465 348 | 2026-06-30 |
| Boundless Bio, Inc. | 4.4% | 1 000 000 | 2026-06-30 |
| Faeth Therapeutics, Inc. | 3.98% | 1 028 242 | 2026-06-30 |
| Parabilis Medicines, Inc. | 3.78% | 4 615 612 | 2026-06-30 |
| MoonLake Immunotherapeutics | 3.77% | 3 205 433 | 2026-06-30 |
| Climb Bio Inc | 3.67% | 2 106 000 | 2026-06-30 |
| Cabaletta Bio Inc | 2.95% | 5 000 000 | 2026-06-30 |
| Quince Therapeutics, Inc. | 0.56% | 5 498 | 2026-06-30 |
| Aardvark Therapeutics, Inc. | — | — | 2025-02-14 |
| OnKure Therapeutics, Inc. | — | — | 2025-05-15 |
advertentie